Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Similar Companies999
Opera Therapeutics
Opera Therapeutics is developing biologic treatments for diabetic retinopathy and stroke-induced edema.
Sector
Subsector
Keywords
Location
total rounds
Aldexa Therapeutics
Aldexa Therapeutics develops treatments for age-related macular degeneration, a leading cause of blindness.
Sector
Subsector
Keywords
Location
total rounds
total raised
Hanugen
Developer of oligonucleotides to treat muscular dystrophy
Sector
Subsector
Location
MitoChem Therapeutics
MitoChem Therapeutics develops treatments to address mitochondrial dysfunction in neurodegenerative diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Horizon Pharma
announced date
price
Financials
Funding Rounds4
Number of Funding Rounds
Money Raised
Their latest funding was raised on 26.01.2016. Their latest round Venture - Series Unknown
Co-Investors
Investors3
Number of lead investors
Number of investors
SR One
SR One Capital Management is a biotech venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Brian Gallagher
current job
Narrow River Management
Narrow River Management is an investment management company specializing in the emerging pharmaceutical industry.
Sector
Subsector
Location
count Of Investments
count Of Exists
Lundbeckfonden Ventures
Lundbeckfonden Ventures is an evergreen venture fund that invests in life science companies, primarily in Europe.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Johan Kördel
Johan Kördel is a senior partner with Lundbeckfond Ventures, a life science venture fund established by the Lundbeck Foundation in 2009. Johan was previously co-founder and CEO of Sound Biotech ApS and co-founder and Senior Vice President of Research and Business Development of Biovitrum AB. Prior to these positions Johan worked almost a decade in the pharmaceutical company Pharmacia with management, research, early development, portfolio management, business development and alliance management. Johan has co-founded other biotech companies and been appointed to numerous board positions both in private and public companies. Johan is an associate professor in Physical Chemistry at the University of Lund, Sweden.
current job
